Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Dose, Infection, and Disease Outcomes for Coronavirus Disease 2019 (COVID-19): A Review.

COVID-19 SARS-CoV-2 disease severity infectious dose inoculum

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
24 08 2022
Historique:
received: 21 07 2021
pubmed: 16 10 2021
medline: 30 8 2022
entrez: 15 10 2021
Statut: ppublish

Résumé

The relationship between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) dose, infection, and coronavirus disease 2019 (COVID-19) outcomes remains poorly understood. This review summarizes the existing literature regarding this issue, identifies gaps in current knowledge, and suggests opportunities for future research. In humans, host characteristics, including age, sex, comorbidities, smoking, and pregnancy, are associated with severe COVID-19. Similarly, in animals, host factors are strong determinants of disease severity, although most animal infection models manifest clinically with mild to moderate respiratory disease. The influence of variants of concern as it relates to infectious dose, consequence of overall pathogenicity, and disease outcome in dose-response remains unknown. Epidemiologic data suggest a dose-response relationship for infection contrasting with limited and inconsistent surrogate-based evidence between dose and disease severity. Recommendations include the design of future infection studies in animal models to investigate inoculating dose on outcomes and the use of better proxies for dose in human epidemiology studies.

Identifiants

pubmed: 34651164
pii: 6397523
doi: 10.1093/cid/ciab903
pmc: PMC8524637
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1195-e1201

Subventions

Organisme : NIH HHS
ID : P51 OD011104
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.

Références

N Engl J Med. 2020 Nov 19;383(21):2092
pubmed: 33095523
Vaccine. 2020 Jul 31;38(35):5653-5658
pubmed: 32651113
Sci Transl Med. 2021 May 12;13(593):
pubmed: 33820835
Ann Intern Med. 2020 Sep 15;173(6):W123-W124
pubmed: 32744870
Cell Rep Med. 2020 Oct 20;1(7):100121
pubmed: 32984855
Lancet. 2021 Jun 26;397(10293):2461-2462
pubmed: 34139198
BMC Infect Dis. 2021 Mar 11;21(1):257
pubmed: 33706702
Nat Commun. 2021 Aug 17;12(1):4985
pubmed: 34404778
Biochem Biophys Res Commun. 2020 May 21;526(1):165-169
pubmed: 32201080
Nature. 2021 Apr;592(7852):116-121
pubmed: 33106671
Cell. 2021 Aug 5;184(16):4203-4219.e32
pubmed: 34242577
Lancet Infect Dis. 2021 Nov;21(11):1518-1528
pubmed: 34171232
Cell. 2021 Jan 7;184(1):64-75.e11
pubmed: 33275900
Animal Model Exp Med. 2020 Mar 30;3(1):93-97
pubmed: 32318665
Nat Med. 2021 Apr;27(4):626-631
pubmed: 33692530
PLoS One. 2021 Mar 23;16(3):e0249090
pubmed: 33755688
JAMA. 2021 Mar 16;325(11):1037-1038
pubmed: 33595644
Sci Adv. 2021 Mar 19;7(12):
pubmed: 33608249
Int J Infect Dis. 2020 Sep;98:180-186
pubmed: 32562846
Int J Clin Pract. 2021 Oct;75(10):e14357
pubmed: 33977626
J Infect. 2020 Aug;81(2):e16-e25
pubmed: 32335169
BMJ. 2021 Jan 26;372:n230
pubmed: 33500262
BMC Infect Dis. 2021 Jul 27;21(1):710
pubmed: 34315427
Ann Intern Med. 2020 Oct 20;173(8):143-144
pubmed: 32915642
Am J Emerg Med. 2020 Sep;38(9):1727-1731
pubmed: 32738467
PLoS Med. 2020 Sep 22;17(9):e1003346
pubmed: 32960881
Clin Infect Dis. 2022 Mar 23;74(6):1097-1100
pubmed: 34145449
Am J Trop Med Hyg. 2020 Sep;103(3):1215-1219
pubmed: 32723427
Lancet Respir Med. 2020 Sep;8(9):e70
pubmed: 32771081
Viruses. 2021 Feb 11;13(2):
pubmed: 33670360
Ann Intern Med. 2020 Dec 1;173(11):W154-W55
pubmed: 33076695
Am J Epidemiol. 2021 Jan 4;190(1):161-175
pubmed: 32870978
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1081-1088
pubmed: 32790664
Cell. 2020 Aug 6;182(3):744-753.e4
pubmed: 32553273
Emerg Microbes Infect. 2020 Dec;9(1):2673-2684
pubmed: 33251966
Nat Commun. 2020 Jul 8;11(1):3496
pubmed: 32641684
Clin Infect Dis. 2020 Dec 3;71(9):2428-2446
pubmed: 32215622
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Lancet Infect Dis. 2021 May;21(5):629-636
pubmed: 33545090
Euro Surveill. 2021 Mar;26(11):
pubmed: 33739254
EBioMedicine. 2021 Apr;66:103291
pubmed: 33813139
Clin Infect Dis. 2022 Feb 11;74(3):407-415
pubmed: 33972994
Nat Commun. 2020 Sep 2;11(1):4400
pubmed: 32879306
BMJ. 2021 Mar 9;372:n579
pubmed: 33687922
Aging (Albany NY). 2020 Jul 13;12(13):12493-12503
pubmed: 32658868
Signal Transduct Target Ther. 2021 Mar 31;6(1):136
pubmed: 33790236
Environ Int. 2020 Nov;144:106039
pubmed: 32822927
Wellcome Open Res. 2020 May 1;5:83
pubmed: 32656368
PLoS Pathog. 2020 Sep 18;16(9):e1008903
pubmed: 32946524
Nature. 2020 Jul;583(7818):834-838
pubmed: 32408338
MMWR Morb Mortal Wkly Rep. 2020 Oct 09;69(40):1450-1456
pubmed: 33031361
Obes Rev. 2020 Oct;21(10):e13095
pubmed: 32686331
Am J Pathol. 2021 Feb;191(2):274-282
pubmed: 33171111
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Ann Intern Med. 2021 Jul;174(7):W63-W64
pubmed: 34058107
Lancet Microbe. 2021 Jan;2(1):e13-e22
pubmed: 33521734
J Assoc Med Microbiol Infect Dis Can. 2020 Dec 31;5(4):223-234
pubmed: 36340059
Nat Commun. 2020 Nov 27;11(1):6078
pubmed: 33247138
N Engl J Med. 2020 Nov 19;383(21):2092-2093
pubmed: 33095524
J Virol. 2020 Oct 27;94(22):
pubmed: 32900822
Ann Intern Med. 2020 Aug 18;173(4):W77
pubmed: 32663033
MMWR Morb Mortal Wkly Rep. 2020 Jun 26;69(25):769-775
pubmed: 32584795
Lancet Infect Dis. 2020 Aug;20(8):e192-e197
pubmed: 32539990
Physiol Rev. 2020 Oct 1;100(4):1455-1466
pubmed: 32496872
Nature. 2021 May;593(7858):270-274
pubmed: 33723411
Cell Host Microbe. 2020 May 13;27(5):704-709.e2
pubmed: 32259477
Cell. 2020 Jul 9;182(1):50-58.e8
pubmed: 32516571
PLoS One. 2020 Aug 26;15(8):e0238215
pubmed: 32845926
Nature. 2020 Jul;583(7818):830-833
pubmed: 32380511
J Exp Med. 2021 Mar 1;218(3):
pubmed: 33211088
Science. 2020 May 29;368(6494):1016-1020
pubmed: 32269068
BMJ. 2020 Sep 1;370:m3320
pubmed: 32873575
Nature. 2020 Oct;586(7830):560-566
pubmed: 32854108
JAMA Netw Open. 2020 Dec 1;3(12):e2031756
pubmed: 33315116
Ann Intern Med. 2021 Apr;174(4):W45-W46
pubmed: 33556273
Cell Host Microbe. 2021 Sep 8;29(9):1437-1453.e8
pubmed: 34428428
Nature. 2021 Jan;589(7843):603-607
pubmed: 33166988
JCI Insight. 2020 Oct 2;5(19):
pubmed: 32841215
Ann Intern Med. 2020 Jul 21;173(2):W46-W47
pubmed: 32515983
Nat Rev Microbiol. 2021 Aug;19(8):528-545
pubmed: 33753932
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Nature. 2020 Sep;585(7826):584-587
pubmed: 32698191
BMJ Glob Health. 2020 Dec;5(12):
pubmed: 33277297
Sci Rep. 2021 Jul 15;11(1):14536
pubmed: 34267262
Clin Infect Dis. 2020 Nov 19;71(16):2139-2149
pubmed: 32472679
Int J Infect Dis. 2020 May;94:91-95
pubmed: 32173574
Ann Intern Med. 2021 Jan;174(1):W18-W19
pubmed: 33226856
Lancet Infect Dis. 2021 Sep;21(9):1246-1256
pubmed: 33857406
J Hosp Infect. 2021 Feb;108:120-134
pubmed: 33212126
Cell Rep. 2021 Jul 27;36(4):109450
pubmed: 34289384
Diseases. 2016 Jul 25;4(3):
pubmed: 28933406
J Med Virol. 2021 Feb;93(2):820-830
pubmed: 32691881
Mucosal Immunol. 2020 Nov;13(6):877-891
pubmed: 32820248
J Microbiol Immunol Infect. 2021 Feb;54(1):12-16
pubmed: 32425996
Cancer Cell. 2020 Nov 9;38(5):661-671.e2
pubmed: 32997958
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Open Life Sci. 2021 Mar 25;16(1):297-302
pubmed: 33817321
Ann Intern Med. 2021 May;174(5):W48-W49
pubmed: 33780293
Viruses. 2020 Jul 20;12(7):
pubmed: 32698441
JAMA. 2021 Feb 9;325(6):529-531
pubmed: 33404586
J Infect. 2020 Dec;81(6):847-856
pubmed: 33049331
Ann Intern Med. 2020 Jul 21;173(2):120-136
pubmed: 32369541
PLoS Pathog. 2021 Jan 19;17(1):e1009195
pubmed: 33465158
Clin Infect Dis. 2021 Jul 30;73(Suppl 2):S170-S176
pubmed: 32964919
Children (Basel). 2020 Jul 01;7(7):
pubmed: 32630212
Nat Commun. 2021 Mar 12;12(1):1653
pubmed: 33712573
Nat Immunol. 2020 Nov;21(11):1327-1335
pubmed: 32839612

Auteurs

Lisa M Brosseau (LM)

Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, Minnesota, USA.

Kevin Escandón (K)

School of Medicine, Universidad del Valle, Cali, Colombia.
Grupo de Investigación en Virus Emergentes y Enfermedad (VIREM), Department of Microbiology, Universidad del Valle, Cali, Colombia.

Angela K Ulrich (AK)

Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, Minnesota, USA.
Division of Environmental Health Sciences, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.

Angela L Rasmussen (AL)

Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Georgetown Center for Global Health Science and Security, Washington, D.C., USA.

Chad J Roy (CJ)

Tulane National Primate Research Center, Division of Microbiology, Covington, Louisiana, USA.
Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.

Gregory J Bix (GJ)

Clinical Neuroscience Research Center, Departments of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Tulane Brain Institute, Tulane University, New Orleans, Louisiana, USA.
School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, USAand.

Saskia V Popescu (SV)

Georgetown Center for Global Health Science and Security, Washington, D.C., USA.
Biodefense Program, Schar School of Policy and Government, George Mason University, Arlington, Virginia, USA.

Kristine A Moore (KA)

Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, Minnesota, USA.

Michael T Osterholm (MT)

Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, Minnesota, USA.
Division of Environmental Health Sciences, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH